← boothcheck

Is ALHC overvalued?

boothcheck doesn't label ALHC overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium). The more the price assumes beyond what ALIGNMENT HEALTHCARE, INC. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from ALIGNMENT HEALTHCARE, INC.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed June 27, 2026.

Implied growth
For about
Margin needed
Margin today
Price vs asset value19.89x
Price vs earnings power4.13x
Price vs peer multiples3.89x
Price vs forward growth0.69x
Read the full ALHC report →
Get boothcheck's read on what ALHC's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.